Private investment company · Enterprise agentic AI
ParkNova Ventures backs enterprise agentic AI — software that completes a task end to end rather than drafting it — and the companies putting it to work in healthcare, pharmaceuticals, and medical technology.
Enterprise agent platforms
Healthcare operations
Pharma & life sciences
Medical technology
Thesis
Most enterprise AI is still stuck at suggestion. A model drafts, a person checks, and the headcount never changes.
Agentic systems break that pattern only when an organization can trust them to complete a task without supervision. In healthcare, pharma, and medical technology, trust is not a feeling — it is a requirement with a paper trail behind it. Every action needs a record, every exception needs a defined escalation path, and someone with a license needs to be on the approval line.
The compliance burden is usually described as the reason these industries adopt late. We think it is the moat.
Building an agent that survives a validation review, a payer audit, or an inspection is slow, unglamorous work that general-purpose tools cannot shortcut. The companies willing to do it inherit workflows nobody else can enter — and they sell into operating budgets, where the money is recurring, rather than innovation budgets, where it is not.
We invest in the platforms that make these agents governable, in the applications built on top of them, and in the operators deploying agents inside their own businesses to run at a cost structure their competitors cannot match.
Where we invest
Application layerAgents doing named jobs
Administrative work inside providers and payers, where hiring another coordinator is not a realistic option.
Buyers: health systems, MSOs, ASCs, payers, billing companies
Document-heavy, deadline-bound processes where the cost of a miss is regulatory rather than commercial.
Buyers: pharma, biotech, CROs, CDMOs
Post-market and commercial operations at device companies, where volume grows faster than the team handling it.
Buyers: device manufacturers, diagnostics, distributors
Platform layer
The layer that makes an agent something a regulated enterprise is allowed to deploy: orchestration across systems of record, permissions that follow a real identity, evaluation and monitoring that hold up in a review, and human checkpoints that are designed in rather than bolted on. Sector-agnostic by construction, but proven fastest where the stakes are highest.
Criteria
This is the whole filter. If it clears, send it. If it does not, send it anyway with one line on why it should be an exception.
How we work
Send the deck or a short email. You get a yes, a no, or one specific question. No NDA required to read a teaser.
If it clears, we come back with a number and a structure before we start spending your time on diligence.
Customer calls, unit economics, security and compliance posture, and a real look at your evals and failure modes.
We tell you at first read whether the capital is committed or whether we need a partner. We do not renegotiate without a written reason.
Contact
Founders can skip the warm intro. A short email describing what the agent replaces, and who currently does that work, is enough to get a real answer. It goes straight to a partner, not to a queue.
ParkNova Ventures LLC